On market trends

There were more numbers of transport/compact emergency care ventilators sold in 2009. The market for mid-segment ventilators is likely to increase further by more than 25 percent.

On type of ventilators

Ventilation segment can be divided into the following types:

• NIV (bi-level ventilators - homecare/RCU) for COPD, neuromuscular disorders, restrictive disorders, obesity and hypoventilation, and periodic breathings
• Transport ventilators (volume and pressure ventilators) for trauma, ambulances, inter hospital shifting, emergency care, and step down ICU (low-end and mid-end)
• ICU ventilators (covers entire range of ventilation modes and lung mechanics) - these ventilators can be further grouped under three categories

On total installation base

Approximately, 15,000-18,000 NIVs are in use in the Indian market and approximately 4000-5000 will be added in 2010. Around 15,000 high-end ICU ventilators are there in the market and 8000 new ICU ventilators will be added in 2010 (low-end to high-end). ResMed has over 55 percent market share in NIV and five percent in transport ventilators.

On emerging trends and new technologies

NIV and compact light-weight multi application ventilators are emerging and will gain over 40 percent of ventilator market share. Most of the companies are launching compact-sized ventilators and trying to pitch in rural hospitals, medium and small sized hospitals, emergency care, and transport.

On challenges and opportunities

Most of the imported ventilators offer a high technology and focus on best clinical outcomes by providing best quality ventilation, however, Indian manufacturers use old and obsolete technologies and the accuracy of set and delivered parameters becomes a question mark. Hence, the quality of ventilation is compromised.

On key achievements

Global expertise. Leading developer, manufacturer and marketer of products for the screening, treatment and management of sleep disordered breathing (SDB) and other respiratory conditions.

Trusted track record

• Stock exchange listing: NYSE: RMD; ASX: RMD.AX
• Excellent leadership and a team of approximately 3000 people with diverse professionals, with technical, marketing, medical and manufacturing skills.
• Continuous innovation'1600 patents and 876 design registrations granted
• 6-7 percent of net revenues invested in research and product development.
• Recognized by Forbes magazine for the tenth consecutive year as one of the 200 Best Small Companies in America.

Improving health. ResMed provides comprehensive treatment solutions including masks, CPAP, automatic and bilevel devices, home care to hospital ventilators, patient monitoring systems and screening tools.

Recently launched S9 series of CPAP machine. A vital ingredient for the S9's success is its comprehensive user insight into the way it is set up and used by physicians and sleep labs, the way it is used in people's home environment and its integration into their life style. ResMed has won 2010 red dot design award for its S9 Series. The sleek design of the CPAP/APAP series is recognized as a success.